These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33324041)

  • 21. Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting.
    Perrone V; Sangiorgi D; Buda S; Degli Esposti L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2749-2755. PubMed ID: 27853362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD.
    Muiser S; Imkamp K; Seigers D; Halbersma NJ; Vonk JM; Luijk BHD; Braunstahl GJ; van den Berg JW; Kroesen BJ; Kocks JWH; Heijink IH; Reddel HK; Kerstjens HAM; van den Berge M
    Thorax; 2023 May; 78(5):451-458. PubMed ID: 36725331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-life effectiveness of budesonide/formoterol therapy in asthma: A subanalysis of the SMARTASIA study.
    Lin J; Tang Y; Xiu Q; Kang J; Cai S; Huang K; Itoh Y; Ling X; Zhong N
    Allergy Asthma Proc; 2016; 37(1):27-34. PubMed ID: 26831844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children.
    Lasserson TJ; Ferrara G; Casali L
    Cochrane Database Syst Rev; 2011 Dec; (12):CD004106. PubMed ID: 22161385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Individual Patient Characteristics and Treatment Choices on Reliever Medication Use in Moderate-Severe Asthma: A Poisson Analysis of Randomised Clinical Trials.
    van Dijkman SC; Yorgancıoğlu A; Pavord I; Brusselle G; Pitrez PM; Oosterholt S; Fumali S; Majumdar A; Della Pasqua O
    Adv Ther; 2024 Mar; 41(3):1201-1225. PubMed ID: 38296921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis of budesonide/formoterol maintenance and reliever therapy versus fixed combination treatments for asthma in Finland*.
    Tamminen K; Laine J; Soini E; Martikainen J; Kankaanranta H
    Curr Med Res Opin; 2008 Dec; 24(12):3453-61. PubMed ID: 19032127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids.
    Huang TM; Kuo KC; Wang YH; Wang CY; Lai CC; Wang HC; Chen L; Yu CJ;
    BMC Infect Dis; 2020 Sep; 20(1):706. PubMed ID: 32977747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of early effects of budesonide/formoterol maintenance and reliever therapy with fluticasone furoate/vilanterol for asthma patients requiring step-up from inhaled corticosteroid monotherapy.
    Hozawa S; Terada M; Haruta Y; Hozawa M
    Pulm Pharmacol Ther; 2016 Apr; 37():15-23. PubMed ID: 26850307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.
    Reynolds NA; Lyseng-Williamson KA; Wiseman LR
    Drugs; 2005; 65(12):1715-34. PubMed ID: 16060707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Budesonide/formoterol versus salmeterol/fluticasone for asthma in children: an effectiveness and safety analysis.
    Jiang P; Zhao L; Yao Z
    J Comp Eff Res; 2021 Dec; 10(17):1283-1289. PubMed ID: 34668718
    [No Abstract]   [Full Text] [Related]  

  • 33. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
    O'Shea O; Stovold E; Cates CJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD007694. PubMed ID: 33852162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacoeconomics analysis of using a fixed combination of budesonide/formoterol in patients with asthma in the health care system of the Russian Federation].
    Zyryanov SK; Dyakov IN; Aisanov ZR
    Ter Arkh; 2022 Aug; 94(7):850-858. PubMed ID: 36286942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
    Hardy J; Baggott C; Fingleton J; Reddel HK; Hancox RJ; Harwood M; Corin A; Sparks J; Hall D; Sabbagh D; Mane S; Vohlidkova A; Martindale J; Williams M; Shirtcliffe P; Holliday M; Weatherall M; Beasley R;
    Lancet; 2019 Sep; 394(10202):919-928. PubMed ID: 31451207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma.
    Bateman ED; Bantje TA; João Gomes M; Toumbis MG; Huber RM; Naya I; Eliraz A
    Am J Respir Med; 2003; 2(3):275-81. PubMed ID: 14720008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of fluticasone/formoterol with budesonide/formoterol pMDI in adults with moderate to severe persistent asthma: Results from a 12-week randomized controlled trial.
    Balki A; Balamurugan S; Bardapurkar S; Dalal S; Singh A; Singh BP; Vaidya A; Gogtay JA
    Pulm Pharmacol Ther; 2018 Feb; 48():28-36. PubMed ID: 28890299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and Effectiveness of As-Needed Formoterol in Asthma Patients Taking Inhaled Corticosteroid (ICS)-Formoterol or ICS-Salmeterol Maintenance Therapy.
    Reddel HK; Brusselle G; Lamarca R; Gustafson P; Anderson GP; Jorup C
    J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2104-2114.e3. PubMed ID: 37054881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS).
    Janson C; Larsson K; Lisspers KH; Ställberg B; Stratelis G; Goike H; Jörgensen L; Johansson G
    BMJ; 2013 May; 346():f3306. PubMed ID: 23719639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study.
    Lundborg M; Wille S; Bjermer L; Tilling B; Lundgren M; Telg G; Ekström T; Selroos O
    Curr Med Res Opin; 2006 May; 22(5):809-21. PubMed ID: 16709303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.